Florida Cancer Specialists & Research Institute Strengthens Local Access to Cancer Care with Physician Appointments in Major Markets
FORT MYERS, Fla., July 14, 2025 /PRNewswire/ — Florida Cancer Specialists & Research Institute, LLC (FCS) welcomes medical oncologists and hematologists Marisabel H. Castillo, MD and Roderick Paras, MD to the statewide practice.
Dr. Castillo is providing care to patients at the FCS Boca Raton clinic, 21020 State Road 7, Ste. 200C, Boca Raton, FL 33428, and the FCS Delray Beach clinic, 5130 Linton Blvd., Ste. B4, Delray Beach, FL 33484.
She graduated magna cum laude from the Central University of Venezuela in Caracas. She received the Outstanding Continuity Clinic Resident Award during her internal medicine residency at New York University and was later appointed chief fellow during her hematology/medical oncology fellowship at the University of Texas at Austin.
'Dr. Castillo is an accomplished physician recognized early in her career for several distinguished achievements, said FCS Assistant Managing Physician David Wenk, MD. 'Through active involvement in clinical research, Dr. Castillo has contributed to the development of innovative immunotherapies as well as strategies to identify and reduce disparities in cancer diagnosis and treatment. She will utilize her skills and dedication to ensure our patients in Palm Beach County attain the best outcomes.'
Dr. Paras is providing care to patients at the FCS cancer centers in Lake Mary, 805 Currency Cir., Lake Mary, FL 32746, Deland, 810 N. Spring Garden Ave., Ste 100, Deland, FL 32720 and Orange City, 2824 Enterprise Rd., Orange City, FL 32763.
After completing his medical degree at the University of Santo Tomas in Manila, Dr. Paras completed internal medicine residency training at New York Medical College's St. Vincent's Medical Center and a fellowship in medical oncology at Medical College of Pennsylvania in Pittsburgh.
FCS President & Managing Physician Lucio N. Gordan, MD, said, 'With a wealth of experience in oncology and a deep commitment to patient-centered care, Dr. Paras brings expertise as well as compassion that will strengthen our mission and elevate the care we provide in Seminole and Volusia counties.'
Dr. Castillo and Dr. Paras are among the growing number of physicians choosing to grow their careers with FCS.
About Florida Cancer Specialists & Research Institute, LLC: (FLCancer.com)
For more than 40 years, Florida Cancer Specialists & Research Institute (FCS) has embraced innovation to deliver world-class care and drive the dramatic transformation of oncology care through its robust clinical research program.
FCS provides patients with access to a wide range of clinical trials, positioning it as a leader in research among private oncology practices in Florida and across the country. In fact, before receiving FDA approval, the majority of new cancer drugs in the U.S. were first made available to patients through participation in clinical trials at FCS.
Our outstanding team of highly trained and dedicated physicians is committed to delivering tailored treatment plans that make the best use of cutting-edge precision oncology advancements to enhance patient outcomes.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malaysian Reserve
5 hours ago
- Malaysian Reserve
Hoag Health Center San Clemente
Hoag's newest health center expands advanced, integrated health care in South Orange County SAN CLEMENTE, Calif., July 14, 2025 /PRNewswire/ — Hoag has officially opened the doors to its newest facility, Hoag Health Center San Clemente, expanding access to world-class, personalized health care for South Orange County residents. As Hoag's 13th health center, the facility strengthens the health system's growing network of care and brings trusted services closer to home for South Orange County patients. The 20,000-square-foot center offers convenient access to primary care, family medicine, internal medicine, urgent care, obstetrics and gynecology, radiology and advanced imaging, as well as specialties including neuroscience, spine, pain management and orthopedic services provided by Hoag Orthopedic Institute surgeons. 'We've built Hoag Health Center San Clemente with our community in mind by integrating cutting-edge technology, a multidisciplinary care model, and a patient-first design to deliver the most advanced care possible,' said Robert T. Braithwaite, Hoag President and Chief Executive Officer. 'This new center reflects our long-term commitment to South Orange County and reinforces Hoag's mission to provide personalized care and an exceptional experience for every patient.' In addition to expanding Hoag's clinical footprint, the health center introduces innovative programs aimed at improving health and longevity. The center is piloting the Hoag Health Lab, a destination for patients to take a proactive approach to their health. It offers baseline evaluations for key health pillars – nutrition, exercise, sleep and community – through nutritional/metabolic assessments, movement and strength benchmarking, and recovery education. An adjacent 3,000-square-foot outdoor patio will host wellness classes and activities. The center is also home to Hoag Compass, Hoag's integrated preventive health program. Compass combines in-depth biomarker testing with digital tools, specialist consults and personalized action plans to help patients better understand their health risks and make sustainable lifestyle changes. No matter the service or specialty, the care delivered at the center will reflect what patients have come to expect from Hoag: personalized attention, strong provider relationships, and seamless coordination between clinical teams. Whether visiting for a routine checkup or a specialty consultation, patients will benefit from a connected, collaborative model of care rooted in innovation, compassion and excellence. Patients will receive this coordinated, personalized care in an environment designed with serenity and sophistication in mind. Hoag Health Center San Clemente features a spacious, open layout that blends natural light, clean architectural lines, and timeless materials. A sprawling, light-filled lobby creates a welcoming first impression with a spa-like aesthetic. Flexible seating and built-in amenities ensure the space supports an exceptional patient experience at every step. Inspired by San Clemente's active, outdoor lifestyle, Hoag Health Center San Clemente was designed to support the way residents live, move and thrive. That includes partnerships with wellness-focused brands that align with the community's values of movement, performance and prevention. 'As a San Clemente resident myself, I'm proud to help bring this new level of care to our community,' Braithwaite added. 'This center is more than a building: It's an investment in the health and vitality of the families who live here.' Hoag Health Center San Clemente is located at 993 Avenida Pico, San Clemente, CA 92673. To learn more or schedule an appointment, visit Photographs of the center are available here. ABOUT HOAGHoag is a nonprofit, regional health care delivery system in Orange County, California. Delivering world-class, comprehensive, personalized care, Hoag consists of 1,800 top physicians, 18 urgent care facilities, 13 health & wellness centers, and two award-winning hospitals. Hoag offers a comprehensive blend of health care services that includes seven institutes providing specialized services in the following areas: cancer, digestive health, heart and vascular, neurosciences, spine, women's health, and orthopedics through Hoag's affiliate, Hoag Orthopedic Institute, which consists of an orthopedic hospital and five ambulatory surgical centers. Hoag is the highest ranked hospital in Orange County by U.S. News & World Report and the only OC hospital ranked in the Top 10 in California, as well as a designated Magnet® with Distinction hospital by the American Nurses Credentialing Center (ANCC). For more information, visit
Malaysian Reserve
7 hours ago
- Malaysian Reserve
Respiratory Care Devices Market worth $33.6 billion by 2030 with 7.3% CAGR
DELRAY BEACH, Fla., July 14, 2025 /PRNewswire/ — The global Respiratory Care Devices Market, valued at US$22.2 billion in 2024 stood at US$23.6 billion in 2025 and is projected to advance at a resilient CAGR of 7.3% from 2025 to 2030, culminating in a forecasted valuation of US$33.6 billion by the end of the period. The advanced wound care market is primarily driven by several factors: the increasing geriatric population, the rising prevalence of chronic diseases, and a growing number of traumatic and burn injuries. These elements have significantly boosted the demand for effective wound management solutions. Furthermore, supportive government initiatives and reimbursement frameworks contribute to market growth. Download PDF Brochure: Browse in-depth TOC on 'Respiratory Care Devices Market' 587 – Tables63 – Figures466 – Pages By product type, Therapeutic devices are necessary for managing and treating the majority of acute and chronic respiratory diseases. They are required to provide patients with COPD, asthma, sleep apnea, and respiratory failure with life-sustaining respiratory therapy. The devices include high-flow nasal cannula systems, CPAP and BiPAP devices, nebulizers, ventilators, and oxygen concentrators. The therapeutic equipment market has increased manifold due to the need for long-term home-based respiratory therapy, the global burden of chronic disease, and the increase in hospitalization. By disease indication, the respiratory care devices market is dominated by Chronic Obstructive Pulmonary Disease (COPD), which is increasingly becoming a global phenomenon, especially in the elderly population. This is due to higher demand for non-invasive ventilators, oxygen concentrators, nebulizers, and monitors. Since COPD is progressive and irreversible, it requires constant care and long-term respiratory therapy. The disease is also escalated by high-risk factors prevalent in developing and developed countries, including smoking, air pollution, and occupational exposures. Furthermore, since COPD is hospitalized and receives exacerbations, constant use of respiratory equipment at home and in the hospital is required. By geography, the respiratory care devices market is segmented into five major regions, namely, North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa. The prevalence of chronic respiratory illnesses such as asthma, COPD, and sleep apnea is partly due to the aging population, extensive histories of smoking, and rising obesity. The strong healthcare infrastructure of the region and growing awareness of the significance of respiratory health enable early detection and treatment of such conditions. The COVID-19 pandemic also drove demand for oxygen therapy equipment and ventilators and hence created long-term interest and investment in respiratory care products. Large medical device firms, improved reimbursement policies, and quick adoption of new technology such as remote monitoring and telephonic integration of respiratory equipment have also driven the market. Request Sample Pages : The key players in the global respiratory care devices market are Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), ResMed Inc. (US), Fisher & Paykel Healthcare Limited (New Zealand), Drägerwerk AG & Co. KGaA (Germany), GE Healthcare (US), Masimo (US), Getinge (Sweden), Nihon Kohden Corporation (Japan), Hillrom & Welch Allyn (Baxter) (US), Teleflex Incorporated (Japan), Air Liquide (France), ICU Medical, Inc (US), AdaptHealth, LLC (US), Hamilton Medical (Switzerland), Medline Industries, LP (US), Allied Medical, LLC (US), Nonin (US), Apex Medical (Taiwan), Rotech Healthcare Inc. (US), Löwenstein Medical SE & Co. KG (Germany), WEINMANN Emergency Medical Technology GmbH + Co. KG (Germany), Drive DeVilbiss Healthcare (US), OMRON Healthcare, Inc (Japan) and HUM GmbH (Germany). Koninklijke Philips N.V. (Netherlands): Koninklijke Philips N.V. is a global health technology leader known for its strong presence in the respiratory care devices market, particularly through its innovative, non-invasive ventilators, CPAP/BiPAP machines, and home oxygen therapy systems. With a strategic focus on integrated care, Philips combines medical devices with AI-powered digital platforms such as HealthSuite to deliver connected solutions across hospital and home settings. The company's core competencies lie in its robust R&D capabilities, global brand presence, and commitment to sustainability. Despite challenges from a global recall of certain respiratory devices, Philips continues to strengthen its position through new product launches. These efforts underline its leadership in delivering advanced, patient-centric respiratory care solutions globally. Medtronic (Ireland) Medtronic plc is one of the world's largest medical technology companies, operating in over 150+ countries. The company has merged its remaining Patient Monitoring and Respiratory Interventions segments into a unified business unit named Acute Care & Monitoring. Its core competencies include its strong presence in chronic disease management, cutting-edge patient monitoring systems, surgical innovations, and global supply chain capabilities. Known for its continuous investment in R&D and digital health integration, the company excels in developing minimally invasive therapies, advanced monitoring devices, and AI-powered diagnostics. Despite withdrawing from ventilator manufacturing, the company remains a major player in hospital-based care solutions, focusing on innovation in acute monitoring and intervention technologies. This restructuring reflects the aim to streamline operations, enhance profitability, and concentrate on higher-growth segments in critical and surgical care. For more information, Inquire Now! Related Reports: Respiratory Diagnostics Market Molecular Diagnostics Market In Vitro Diagnostics Market Point of Care Molecular Diagnostics Market Infectious Disease Diagnostics Market Get access to the latest updates on Respiratory Care Devices Companies and Respiratory Care Devices Market Size About MarketsandMarkets™: MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter , LinkedIn and Facebook . Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC.1615 South Congress 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@ Our Website: Logo: View original content:
Malaysian Reserve
9 hours ago
- Malaysian Reserve
Florida Cancer Specialists & Research Institute Strengthens Local Access to Cancer Care with Physician Appointments in Major Markets
Statewide Practice Welcomes Medical Oncologist & Hematologist Marisabel H. Castillo, MD to Palm Beach County; Medical Oncologist & Hematologist Roderick Paras, MD to Central Florida FORT MYERS, Fla., July 14, 2025 /PRNewswire/ — Florida Cancer Specialists & Research Institute, LLC (FCS) welcomes medical oncologists and hematologists Marisabel H. Castillo, MD and Roderick Paras, MD to the statewide practice. Dr. Castillo is providing care to patients at the FCS Boca Raton clinic, 21020 State Road 7, Ste. 200C, Boca Raton, FL 33428, and the FCS Delray Beach clinic, 5130 Linton Blvd., Ste. B4, Delray Beach, FL 33484. She graduated magna cum laude from the Central University of Venezuela in Caracas. She received the Outstanding Continuity Clinic Resident Award during her internal medicine residency at New York University and was later appointed chief fellow during her hematology/medical oncology fellowship at the University of Texas at Austin. 'Dr. Castillo is an accomplished physician recognized early in her career for several distinguished achievements, said FCS Assistant Managing Physician David Wenk, MD. 'Through active involvement in clinical research, Dr. Castillo has contributed to the development of innovative immunotherapies as well as strategies to identify and reduce disparities in cancer diagnosis and treatment. She will utilize her skills and dedication to ensure our patients in Palm Beach County attain the best outcomes.' Dr. Paras is providing care to patients at the FCS cancer centers in Lake Mary, 805 Currency Cir., Lake Mary, FL 32746, Deland, 810 N. Spring Garden Ave., Ste 100, Deland, FL 32720 and Orange City, 2824 Enterprise Rd., Orange City, FL 32763. After completing his medical degree at the University of Santo Tomas in Manila, Dr. Paras completed internal medicine residency training at New York Medical College's St. Vincent's Medical Center and a fellowship in medical oncology at Medical College of Pennsylvania in Pittsburgh. FCS President & Managing Physician Lucio N. Gordan, MD, said, 'With a wealth of experience in oncology and a deep commitment to patient-centered care, Dr. Paras brings expertise as well as compassion that will strengthen our mission and elevate the care we provide in Seminole and Volusia counties.' Dr. Castillo and Dr. Paras are among the growing number of physicians choosing to grow their careers with FCS. About Florida Cancer Specialists & Research Institute, LLC: ( For more than 40 years, Florida Cancer Specialists & Research Institute (FCS) has embraced innovation to deliver world-class care and drive the dramatic transformation of oncology care through its robust clinical research program. FCS provides patients with access to a wide range of clinical trials, positioning it as a leader in research among private oncology practices in Florida and across the country. In fact, before receiving FDA approval, the majority of new cancer drugs in the U.S. were first made available to patients through participation in clinical trials at FCS. Our outstanding team of highly trained and dedicated physicians is committed to delivering tailored treatment plans that make the best use of cutting-edge precision oncology advancements to enhance patient outcomes.
